Amer Sami

1.5k total citations
23 papers, 551 citations indexed

About

Amer Sami is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Amer Sami has authored 23 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Amer Sami's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (5 papers). Amer Sami is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (5 papers). Amer Sami collaborates with scholars based in Canada, United States and China. Amer Sami's co-authors include Shahid Ahmed, Jim Xiang, Kamal Haider, Riaz Alvi, Sunil Kumar Yadav, Ali El‐Gayed, J Xiang, Imran Ahmad, Tim Hon Man Chan and David R. Popkin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Amer Sami

22 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amer Sami Canada	12	344	184	132	102	93	23	551
Ana T. Nunes United States	11	275 0.8×	120 0.7×	81 0.6×	55 0.5×	71 0.8×	19	455
Felipe G. Gercovich Argentina	7	218 0.6×	83 0.5×	41 0.3×	51 0.5×	65 0.7×	29	439
Anna Maria Granato Italy	17	365 1.1×	246 1.3×	211 1.6×	35 0.3×	36 0.4×	38	657
Heran Deng China	13	262 0.8×	130 0.7×	53 0.4×	55 0.5×	67 0.7×	31	577
Michel Delforge Belgium	17	509 1.5×	486 2.6×	113 0.9×	31 0.3×	89 1.0×	111	1.0k
Petros Fessas United Kingdom	8	341 1.0×	91 0.5×	141 1.1×	58 0.6×	49 0.5×	14	529
C. Mascaux Belgium	12	375 1.1×	225 1.2×	86 0.7×	113 1.1×	70 0.8×	22	704
Daniele Pozzessere Italy	14	230 0.7×	114 0.6×	103 0.8×	40 0.4×	35 0.4×	24	426
Smitha Menon United States	11	300 0.9×	134 0.7×	75 0.6×	47 0.5×	20 0.2×	18	474

Countries citing papers authored by Amer Sami

Since Specialization

Citations

This map shows the geographic impact of Amer Sami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer Sami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer Sami more than expected).

Fields of papers citing papers by Amer Sami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amer Sami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer Sami. The network helps show where Amer Sami may publish in the future.

Co-authorship network of co-authors of Amer Sami

This figure shows the co-authorship network connecting the top 25 collaborators of Amer Sami. A scholar is included among the top collaborators of Amer Sami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amer Sami. Amer Sami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chalchal, Haji, Ali El‐Gayed, Peter Graham, et al.. (2023). Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study. Cancers. 15(7). 1995–1995. 1 indexed citations

Le, Duc, Prosanta Mondal, Amer Sami, et al.. (2022). Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study. Scientific Reports. 12(1). 1068–1068. 11 indexed citations

Sami, Amer, Kamal Haider, Haji Chalchal, et al.. (2021). Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience. Cancers. 13(16). 4163–4163. 4 indexed citations

Sami, Amer, et al.. (2021). Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer. Current Oncology. 28(3). 1803–1822. 36 indexed citations

Burbridge, Brent, et al.. (2021). Comparison of the Quality of Life of Patients with Breast or Colon Cancer with an Arm Vein Port (TIVAD) Versus a Peripherally Inserted Central Catheter (PICC). Current Oncology. 28(2). 1495–1506. 20 indexed citations

Xie, Yufeng, Jie Wu, Aizhang Xu, et al.. (2018). Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice. Vaccine. 36(11). 1414–1422. 25 indexed citations

Ahmed, Shahid, et al.. (2015). HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy. 5(2). 106–128. 5 indexed citations

Ahmed, Shahid, Amer Sami, & Jim Xiang. (2015). HER2-directed therapy: current treatment options for HER2-positive breast cancer. Breast Cancer. 22(2). 101–116. 143 indexed citations

Ahmed, Shahid, Punam Pahwa, Selliah Kanthan, et al.. (2015). Surgical management of the primary tumor in stage IV colorectal cancer: A validation study.. Journal of Clinical Oncology. 33(3_suppl). 675–675.

10.

Xie, Yufeng, Y Chen, Khawaja Ashfaque Ahmed, et al.. (2013). Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses. Cancer Gene Therapy. 20(10). 590–598. 16 indexed citations

11.

Wang, Lu, Yufeng Xie, Khawaja Ashfaque Ahmed, et al.. (2013). Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice. Breast Cancer Research and Treatment. 140(2). 273–284. 42 indexed citations

12.

Chen, Y, Yufeng Xie, Tim Hon Man Chan, et al.. (2011). Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice. Cancer Gene Therapy. 18(7). 489–499. 10 indexed citations

13.

Ahmed, Shahid, Imran Ahmad, Tong Zhu, et al.. (2010). Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based Study. Diseases of the Colon & Rectum. 53(10). 1432–1438. 41 indexed citations

14.

Martín, Miguel, John R. Mackey, Tadeusz Pieńkowski, et al.. (2010). Abstract S4-3: Ten-Year Follow-Up Analysis of the BICRG 001 Trial Confirms Superior DFS and OS Benefit of Adjuvant TAC (Docetaxel, Doxorubicin, Cyclophosphamide) over FAC (fluorouracil, Doxorubicin, Cyclophosphamide) in Women with Operable Node-Positive Breast Cancer. Cancer Research. 70(24_Supplement). S4–3. 2 indexed citations

15.

Chan, Tim Hon Man, et al.. (2008). Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice. Cancer Gene Therapy. 15(10). 655–666. 22 indexed citations

16.

Chan, Tim Hon Man, Amer Sami, Ali El‐Gayed, Xulin Guo, & J Xiang. (2006). HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination. Gene Therapy. 13(19). 1391–1402. 32 indexed citations

17.

Ye, Zhenmin, Zhuang Chen, Amer Sami, Ali El‐Gayed, & Jim Xiang. (2006). Human Dendritic Cells Engineered to Express Alpha Tumor Necrosis Factor Maintain Cellular Maturation and T-Cell Stimulation Capacity. Cancer Biotherapy and Radiopharmaceuticals. 21(6). 613–622. 12 indexed citations

18.

Haider, Kamal, Rabia Shahid, Daygen L. Finch, et al.. (2006). Extrapulmonary small cell cancer. Cancer. 107(9). 2262–2269. 101 indexed citations

19.

Haider, Kamal, Daygen L. Finch, Amer Sami, et al.. (2004). Largest series of extrapulmonary small cell carcinoma (ESCC): The Saskatchewan Experience. Journal of Clinical Oncology. 22(14_suppl). 9681–9681. 1 indexed citations

20.

Schwartz, Kenneth A., et al.. (2002). A new method for measuring inhibition of platelet function by nonsteroidal antiinflammatory drugs. Journal of Laboratory and Clinical Medicine. 139(4). 227–233. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact